GEN Exclusives

More »

GEN News Highlights

More »
Nov 14, 2008

Cellular Dynamics Receives SBIR Grant

  • Cellular Dynamics International (CDI) received an SBIR grant from the NIH worth $499,796 to develop pluripotent stem-cell derived human cardiomyocytes (CMs), or heart cells. Human CMs will provide a more predictive model to determine cardiotoxicity in the early stages of drug development, according to the company.

    CDI will use human pluripotent stem cells to derive pure populations of cardiomyocytes (atrial, ventricular, and nodal) for development of preclinical models to accurately predict cardiac toxicity in humans during the early stages of drug discovery. These models will allow for detection of drug toxicity and significantly reduce the chances of a cardiotoxic compound ever reaching a clinical population, thus improving the overall efficiency and safety of the drug development process, the company adds.

    This is the second SBIR grant awarded to CDI this year, with a combined total of approximately $1 million.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »